Improving Affordability in Cancer Care Through Economic Screening and Support (I-ACCESS)

Part of paid clinical trials in New York, New York.

Sponsor
UNC Lineberger Comprehensive Cancer Center
Study ID
NCT07664436
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cancer
  • Financial Burden
  • Financial Toxicity
  • Screening Tool

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Financial counseling and navigation — BEHAVIORAL
    Patients who screen positive for financial toxicity on the 2-question screener tool, will be referred to available counseling or navigation resources available at each site.

Study Details

Screening and referral program to proactively identify financial hardship in adult patients with cancer and connect those at-risk with education, counseling, and resources. Patients with cancer will be screened as part of routine care and referred to available resources at their institution, following the referral processes developed and mapped in Aim 1.

Key Dates

Start date
Sep 1, 2027
Status verified
Jun 2026
Primary completion
Apr 1, 2029
Completion
Sep 1, 2029

Study Design

Enrollment
220 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Other: Financial Screener
    Determine the effectiveness of the I-ACCESS screening tool in facilitating patient referrals for financial hardship counseling across diverse clinical practice settings. Patients who meet inclusion criteria will be screened for financial toxicity for financial toxicity using a 2-question screener tool developed from the COST ( a financial toxicity screening measure). Patients who screen positive for financial toxicity will be appropriately referred to available counseling resources.

Primary Outcome Measure

Screening completion [ Time Frame: From enrollment to the end of the intervention at 8 months. ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Perlmutter Cancer CenterNew YorkNew York10016
Brianna Connelly
[email protected]
919-964-2343
Bridgette
[email protected]
646-221-6953
Cone Health Alamance RegionalBurlingtonNorth Carolina27215
Brianna Connelly
[email protected]
919-964-2343
Bridgette Thom
[email protected]
646-221-6953
University of North Carolina at Chapel HillChapel HillNorth Carolina27599-
UNC Health PardeeHendersonvilleNorth Carolina28791
Brianna Connelly
[email protected]
919-964-2343
Bridgette Thom
[email protected]
646-221-6953

Find similar trials in New York, NY

By research site
Perlmutter Cancer Center· New York, NYCone Health Alamance Regional· Burlington, NCUniversity of North Carolina at Chapel Hill· Chapel Hill, NCUNC Health Pardee· Hendersonville, NC

Related Studies